Cantor Fitzgerald Reiterates Overweight on Surgery Partners, Maintains $18 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 50.3%

Neg 0% Neu 50.3% Pos 0%

Cantor Fitzgerald analyst Sarah James reiterates Surgery Partners (NASDAQ:SGRY) with a Overweight and maintains $18 price target.